PharmaBoardroom

PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have…

KV Kumar, head of the Indian American International Chamber of Commerce, gives an account of the bilateral trade relations between India and the US…

Ian Wilders of Spain-headquartered micro-immunotherapy specialist Labo’Life discusses the strategic importance of Belgium to the company as the…

Located in the heart of the UAE, Dubai Airports owns and manages the operation and development of both of the city’s airports, Dubai International…

Charlotte Kremer is head of medical affairs for Astellas Pharma and serves as the president of the Medical Affairs Professional Society. At…

Françoise Smets, dean of the Faculty of Medicine and Dentistry at Université Catholique de Louvain (UCLouvain), introduces the innovation and…

According to Peter Holchacker, director general of Hungary’s Association of Innovative Pharmaceutical Manufacturers (AIPM), “clinical trials…

Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours.…

In 2016, Hungary transitioned from a second-tier member to a full member of the EU. As Judit Bidló, deputy director general of pricing and…

Digital health deal values in biopharma jumped to USD 6.4 billion in 2019, largely thanks to software company Dassault Systemes Americas Corp.'s USD…

With so many wild predictions being bandied around about AI’s potential to radically transform healthcare for the better, it is easy to lose sight…

As data and information proliferate at an exponential pace, many industries have turned to artificial intelligence to make sense of this information…